The oral microbiome as a regulatory hub for systemic health: a systematic review of mechanistic links and clinical implications
Journal of Oral Microbiology · 31.12.2026 · 18 (1)
DOI: 10.1080/20002297.2026.2635233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Oral Microbiology, online erschienen am 03.03.2026. Verfasst von Zhu Ling Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management Center, The First Affiliated Hospital of Hainan Medical University, Haikou, People's Republic of China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Academic Enhancement Support Program of Hainan Medical University, the Hainan S&T Program.
Abstract (Originalsprache)
Background
The human oral microbiome is a highly diverse ecosystem with important roles in oral and systemic health. Beyond dental caries and periodontitis, oral dysbiosis has been increasingly implicated in the development of multiple non-communicable diseases.
Objective
To systematically synthesize evidence on the mechanisms linking oral dysbiosis to systemic diseases and to summarize its diagnostic and therapeutic implications.
Design
A systematic review was performed using major electronic databases. We screened 1,128 records and included 104 studies that met predefined eligibility criteria.
Results
Evidence indicates that oral dysbiosis may influence systemic health through several mechanisms, including hematogenous dissemination of oral pathogens and virulence factors (e.g. lipopolysaccharide), chronic systemic inflammation, molecular mimicry in autoimmune disorders, and microbial metabolic byproducts. The reviewed studies support associations between oral microbiome alterations and atherosclerotic cardiovascular disease, type 2 diabetes, Alzheimer's disease, rheumatoid arthritis, and gastrointestinal cancers. The literature also highlights the promise of non-invasive oral microbiome-based biomarkers for early detection and disease monitoring. Emerging microbiome-modulating interventions, including probiotics, prebiotics, and bacteriophage therapy, show potential for restoring oral eubiosis and improving systemic outcomes.
Conclusions
Oral dysbiosis is an important regulator of systemic disease processes and a promising target for diagnosis, prevention, and therapy. Integrating oral health and oral microbiome assessment into broader disease management may improve outcomes, although methodological standardization and stronger causal evidence are still needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Management Center, The First Affiliated Hospital of Hainan Medical University, Haikou, People's Republic of China.
- School of Dentistry, Hainan Medical University, Haikou, People's Republic of China.
- Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Förderung
- National Natural Science Foundation of China
- the Academic Enhancement Support Program of Hainan Medical University
- the Hainan S&T Program
Zitieren
APA
Guo, Z. L., Cui, M. W., Dong, Y. L., & Wang, S. (2026). The oral microbiome as a regulatory hub for systemic health: a systematic review of mechanistic links and clinical implications. Journal of Oral Microbiology, 18(1). https://doi.org/10.1080/20002297.2026.2635233
Vancouver
Guo ZL, Cui MW, Dong YL, Wang S. The oral microbiome as a regulatory hub for systemic health: a systematic review of mechanistic links and clinical implications. Journal of Oral Microbiology. 2026;18(1). doi:10.1080/20002297.2026.2635233
BibTeX
@article{Guo2026,
author = {Guo, Zhu Ling and Cui, Ming Wang and Dong, Yu Lei and Wang, Shuai},
title = {The oral microbiome as a regulatory hub for systemic health: a systematic review of mechanistic links and clinical implications},
journal = {Journal of Oral Microbiology},
year = {2026},
volume = {18},
number = {1},
doi = {10.1080/20002297.2026.2635233}
}
EUVIMED